Related Experiment Videos
Relation between gliadin structure and coeliac toxicity
1German Research Institute of Food Chemistry, Garching, Germany.
Summary
Gliadin, a wheat protein toxic to coeliac patients, contains specific peptide sequences in its alpha-type components that activate the disease. These toxic sequences are conserved across different wheat species.
Area of Science:
- Immunology
- Gastroenterology
- Food Science
Background:
- Gliadin, a protein fraction in wheat, is implicated as the toxic agent in coeliac disease.
- Gliadin comprises several types (omega-5, omega-1,2, alpha, gamma), with alpha- and gamma-types possessing distinct domain structures.
Purpose of the Study:
- To identify the specific components and sequences within gliadin responsible for coeliac disease toxicity.
- To investigate the role of alpha-type gliadin domains and specific peptide sequences in disease activation.
Main Methods:
- Classification of gliadin components based on primary structure.
- In vivo and in vitro testing of gliadin and its peptides for toxicity.
- Analysis of amino acid sequences, focusing on repetitive domains and specific peptide motifs.
Main Results:
- Alpha-type gliadins were confirmed as toxic in vivo.
- Domain I of alpha-type gliadins was identified as crucial for activating coeliac disease.
- The peptide sequences -Pro-Ser-Gln-Gln- and -Gln-Gln-Gln-Pro- were found to be common in toxic gliadin peptides and critical for toxicity.
- No significant differences in toxic alpha-type gliadin sequences were observed across various cultivated wheat species.
Conclusions:
- Specific peptide sequences within alpha-type gliadin domains are key triggers for coeliac disease.
- Gliadin's toxicity is resistant to standard digestive enzymes.
- Understanding these toxic sequences can inform future coeliac disease research and management.